Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 1,487 | 1,592 | 1,138 | 1,459 | 1,447 |
| Cost of Goods | 690 | 850 | 560 | 720 | 670 |
| Gross Profit | 790 | 770 | 570 | 730 | 760 |
| Operating Expenses | 1,300 | 1,440 | 1,160 | 1,400 | 1,220 |
| Operating Income | 187 | 152 | -22 | 59 | 227 |
| Interest Expense | 9 | 1 | 9 | 10 | 10 |
| Other Income | 12 | 49 | 21 | 11 | 3 |
| Pre-tax Income | 190 | 200 | -10 | 60 | 220 |
| Income Tax | 70 | -1,740 | 0 | 0 | 0 |
| Net Income Continuous | 116 | 1,627 | -13 | 64 | 227 |
| Net Income | $116 | $1,627 | $-13 | $64 | $227 |
| EPS Basic Total Ops | 0.04 | 0.62 | -0.01 | 0.02 | 0.09 |
| EPS Basic Continuous Ops | 0.04 | 0.62 | 0.00 | 0.02 | 0.09 |
| EPS Diluted Total Ops | 0.04 | 0.58 | -0.01 | 0.02 | 0.08 |
| EPS Diluted Continuous Ops | 0.04 | 0.62 | 0.00 | 0.02 | 0.08 |
| EBITDA(a) | $217 | $192 | $8 | $89 | $257 |